Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 1 · 50%GRADE not reported 0 · 0%Very low 1 · 50%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

80% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents

It is very uncertain whether ethosuximide changes 80% or greater reduction in seizure frequency compared with valproate (very low certainty).

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
RR 0.7 [0.19, 2.59]
1 study · 29 participants
Very low

80% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found